Skip to main content

Table 4 Cumulative use of analgesics, sedatives, and vasopressors

From: Adjunctive ketamine for sedation in critically ill mechanically ventilated patients: an active-controlled, pilot, feasibility clinical trial

 

Baseline

48 h post-randomization

All (N = 83)

CG (N = 43)

Ketamine (N = 40)

p

All (N = 83)

CG (N = 43)

Ketamine (N = 40)

p

Fentanyl (μg)

1475 (681–2600)

1262 (488–2612)

1612 (1100–2512)

0.17

3938 (2100–6400)

3817 (2220–6140)

4400 (1588–7700)

0.67

Fentanyl (μg/kg)

23.4 (9.9–39.7)

21 (7.37–37.2)

26.4 (15.7–43.2)

0.22

66.8 (26.6–105)

63.5 (32.8–97.1)

69.6 (22.7–110)

0.69

Propofol (mg)

755 (172–1738)

780 (150–1425)

640 (215–1850)

0.37

1990 (530–3862)

2091 (492–3316)

1815 (778–4272)

0.95

Propofol (mg/kg)

10.9 (3.26–24.7)

12.7 (2.13–22.2)

10.6 (4.38–25.3)

0.63

28.4 (9.29–59)

28.4 (6.59–58.1)

28 (9.62–60.9)

1

Midazolam (mg)

5 (3–5.75)

4.75 (2–5.38)

5 (3–6)

0.54

12.5 (5.25–101)

7 (4.5–76.8)

62.8 (17.1–125)

0.11

Midazolam (mg/kg)

0.08 (0.04–0.13)

0.08 (0.04–0.13)

0.08 (0.05–0.12)

0.89

0.24 (0.1–1.25)

0.15 (0.08–0.49)

0.85 (0.26–1.74)

0.16

Dexmedetomidine (μg)

    

667 (357–1222)

667 (357–1222)

711 (310–1730)

0.90

Dexmedetomidine (μg/kg)

    

9.34 (5.33–22.8)

9.34 (5.33–22)

18 (4.67–35.5)

0.63

Norepinephrine (mg)

5.92 (2.5–12.1)

5.92 (1.82–10.7)

6.35 (3.53–14.2)

0.38

9 (4.92–28)

8.63 (6.13–26)

9.37 (4.4–28.4)

0.89

Epinephrine (mg)

1.17 (0.43–1.37)

1.24 (0.53–1.5)

0.81 (0.47–1.15)

0.36

6.09 (2–13.1)

29.2 (29.2–29.2)

4.04 (1.88–11.35)

0.16

Phenylephrine (mg)

0.45 (0.3–1.1)

0.45 (0.3–1.3)

0.45 (0.3–0.7)

0.78

0.60 (0.21–46.8)

36 (0.5–57.6)

0.45 (0.17–43.9)

0.52

Dopamine (mg)

133 (70.6–203)

133 (110–156)

149 (86.2–213)

1

563 (490–676)

563 (482–619)

602 (546–659)

0.56

Vasopressin (units)

18.2 (11.4–27.9)

12 (9.6–15)

39.6 (30.5–64.2)

0.05

70.8 (30–91.6)

24 (21.6–82.8)

81.6 (60–89.6)

0.20

  1. Data presented as median (interquartile range)
  2. Cumulative use at baseline donates to total amount of analgesics, sedatives, and vasopressors from ICU admission till the time of randomization. Cumulative use at 48 h donates to total amount of analgesics, sedatives, and vasopressors from time of randomization to 48 h thereafter
  3. CG control group (donates to standard of care)